MATLIN DAVID J bought TLSI
May 14, 2026 · Form 4 insider transaction
MATLIN DAVID J bought 56,403 shares of TriSalus Life Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
56,403
Price
$0.00
Total value
N/A
InsiderMATLIN DAVID J
Role—
SecurityDirector Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 14, 2026
Filing dateMay 15, 2026
Shares owned after121,403
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.